Critical Analysis Paper Notes

Critical Analysis Paper Notes - Facts Assumptions Vioxx...

Info iconThis preview shows pages 1–2. Sign up to view the full content.

View Full Document Right Arrow Icon
Facts Vioxx, Merck’s once best-selling prescription painkiller had been pulled off the market in September 2004 after Merck leaned it increased the risk of heart attacks and strokes (p480) Vioxx became a blockbuster drug, generating $2.1 billion in US sales and contributing almost 10% of Merck’s total sales revenue worldwide. o FDA scientist estimated that 139,000 in the US had heart attacks or strokes as a result of taking Vioxx, and about 55,000 of these had died (p481) More than 6,000 lawsuits were filed alleging that Vioxx had caused death or disability o Merrill Lynch estimated the company’s liability for compensatory damages along in the range of $4 to $18 billion (p482) Some felt that company’s culture had been shaped by its research agenda o The author of a history of Merck commented that the company was “intense, driven, loyal, scientifically brilliant, collegial, and arrogant.” (p481) o The company vigorously maintained that it had done nothing wrong and vowed to defend every single case in court (482)
Background image of page 1

Info iconThis preview has intentionally blurred sections. Sign up to view the full version.

View Full DocumentRight Arrow Icon
Image of page 2
This is the end of the preview. Sign up to access the rest of the document.

This note was uploaded on 09/08/2011 for the course MAN 4701 taught by Professor Putchinski,l during the Spring '08 term at University of Central Florida.

Page1 / 2

Critical Analysis Paper Notes - Facts Assumptions Vioxx...

This preview shows document pages 1 - 2. Sign up to view the full document.

View Full Document Right Arrow Icon
Ask a homework question - tutors are online